Danny Prosky Acquires 25,000 Shares of American Healthcare REIT, Inc. (NYSE:AHR) Stock

American Healthcare REIT, Inc. (NYSE:AHR) CEO Danny Prosky acquired 25,000 shares of American Healthcare REIT stock in a transaction on Wednesday, May 22nd. The shares were purchased at an average price of $14.20 per share, for a total transaction of $355,000.00. Following the completion of the purchase, the chief executive officer now directly owns 108,333 shares of the company’s stock, valued at $1,538,328.60. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

American Healthcare REIT Stock Up 1.1 %

Shares of AHR opened at $14.00 on Friday. The company has a quick ratio of 0.33, a current ratio of 0.33 and a debt-to-equity ratio of 0.60. American Healthcare REIT, Inc. has a 12-month low of $12.63 and a 12-month high of $14.90. The stock has a 50-day moving average price of $13.90.

American Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 19th. Investors of record on Thursday, March 28th were issued a $0.25 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $1.00 dividend on an annualized basis and a yield of 7.14%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on AHR shares. JMP Securities reaffirmed a “market outperform” rating and set a $16.00 price target on shares of American Healthcare REIT in a report on Thursday, May 16th. Citigroup started coverage on American Healthcare REIT in a research note on Monday, March 4th. They set a “neutral” rating and a $14.00 target price for the company. Truist Financial decreased their price target on American Healthcare REIT from $17.00 to $16.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. Royal Bank of Canada started coverage on American Healthcare REIT in a research note on Monday, March 4th. They issued an “outperform” rating and a $15.00 price objective on the stock. Finally, KeyCorp began coverage on American Healthcare REIT in a research report on Monday, March 4th. They issued an “overweight” rating and a $16.00 target price on the stock. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $15.88.

Institutional Investors Weigh In On American Healthcare REIT

Hedge funds have recently added to or reduced their stakes in the business. Virtu Financial LLC acquired a new position in American Healthcare REIT in the 1st quarter valued at approximately $308,000. Kodai Capital Management LP acquired a new stake in American Healthcare REIT in the first quarter valued at $336,000. Peak Financial Advisors LLC bought a new position in American Healthcare REIT during the 1st quarter worth $416,000. Quadrature Capital Ltd acquired a new position in American Healthcare REIT during the 1st quarter worth about $914,000. Finally, Seven Grand Managers LLC bought a new stake in shares of American Healthcare REIT in the 1st quarter valued at about $1,032,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.